Company Active LTD

Company profile

Doctor Flint Limited

Dr Flint

Doctor Flint Limited is a UK company with status active founded in 2015 based in Scotland.

CRN
SC500992
Founded
2015
Age
11

Overview

Legal name
DOCTOR FLINT LIMITED
Region
Scotland
Registered address
36 BARNTON AVENUE
EDINBURGH
SCOTLAND
EH4 6JL
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

5 events
17 Mar
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

03 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

19 Mar
2015

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2018
Funded years
2018, 2020, 2022
Age at first award
2 years

Projects

2022 Collaborative R&D Lead participant

The Safer Prescription of Opioids Tool USA Market feasibility study

1 Jan 2022 to 31 Mar 2022

Awarded
£20,975
Total cost £29,965

SPOT - The Safer Prescription of Opioids Tool is a novel digital health platform, distributed as software as a service, which is proven to significantly improve the confidence of opioid prescribing and adherence to best practice guidelines. SPOT has been featured by the BBC and is one of SDI's top 12 Digital Health innovations to watch in 2020\. SPOT has ...

2020 Collaborative R&D Lead participant

SPOT - The Safer Prescription of Opioids Tool - National Scale-up and Deployment

1 Nov 2020 to 31 May 2021

Awarded
£68,376
Total cost £68,376

SPOT, The Safer Prescription of Opioids Tool, supports prescribers when relieving pain at the end-of-life. It has been featured in the BBC on TV and online, and it is currently in use in NHS Borders to support palliative care of patients. The COVID19 pandemic is creating an increased demand for drugs (known as Opioids) that relieve pain at the end of life...

2018 Feasibility Studies Lead participant

SPOT - The Safer Prescription of Opioids Tool

1 Feb 2018 to 30 Nov 2018

Awarded
£52,500
Total cost £75,000

"A number of strong painkillers, morphine derivatives, are used in the management of patients with cancer pain. Intolerance to these drugs or side effects involves switching to another type of drug, or route of administration. Converting from one painkiller to another requires care and is presently performed using paper tables of approximate equivalence. ...

Product types

Collaborative R&D Feasibility Studies